Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures for BARDA

Solicitation Number: BAA-13-100-SOL-00013
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Acquisitions Management, Contracts, & Grants (AMCG)
  • Print


There have been modifications to this notice. To view the most recent modification/amendment, click here
Added: Jul 16, 2013 11:39 am
BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the 2012 PHEMCE Implementation Plan for CBRN Threats. The Implementation Plan is located on the ASPR website:

The Pandemic and All Hazard Preparedness Act Pub. L. No. 109-417, 42 U.S.C. § 241 et seq. (PAHPA; and The Pandemic and All Hazard Preparedness Reauthorization Act Pub. L. No. 113-5, (PAHPRA: authorizes BARDA to (i) conduct ongoing searches for, and support calls for, potential qualified countermeasures and qualified pandemic or epidemic products; (ii) direct and coordinate the countermeasure and product advanced research and development activities of the Department of Health and Human Services; (iii) establish strategic initiatives to accelerate countermeasure and product advanced research and development (which may include advanced research and development for purposes of fulfilling requirements under the Federal Food, Drug, and Cosmetic Act or section 351 of this Act) and innovation in such areas as the Secretary may identify as priority unmet need areas; and (iv) award contracts, grants, cooperative agreements, and enter into other transactions, for countermeasure and product advanced research and development.

Areas of Interest:

The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I.

Research Areas of Interest:
1. Vaccines
2. Antitoxins and Therapeutics
3. Antimicrobial Drugs
4. Radiological/Nuclear Threat Medical Countermeasures
5. Chemical Threat Medical Countermeasures
6. Clinical Diagnostics Tools

BARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS).

The Government intends to have a full & open competition for this requirement in the form of a BAA. This synopsis is not a BAA; a BAA itself is anticipated to be posted on or about July 31, 2013. The Government expects to make 1 or more awards, subject to the availability of funds. The open period of the BAA will be specified in the BAA itself.

Contact Information:

Comments to this announcement, referencing synopsis BAA- 13-100-SOL-00013 may be submitted to the following email address:

Contracting Office Address:

Department of Health & Human Services (DHHS)
Office of the Assistant Secretary for Preparedness & Response (ASPR)
Acquisition Management Contracts & Grants (AMCG)
330 Independence Ave., S.W., Room G-640
Washington, D.C. 20201

Added: Jul 31, 2013 2:51 pm
The Government intends to promote and provide for full & open competition under this requirement through the use of this BAA. The Government expects to make 1 or more awards, subject to the availability of funds. This advertisement does not commit the Government to award a contract.

Pre-proposal Conference:

A Multi-BAA Pre-Proposal Conference is scheduled for September 4, 2013 in Washington, D.C. Advance registration is required. For additional information, and to register, please visit:


Added: Sep 06, 2013 3:18 pm
The presentation slides from the Multi-BAA Pre-Proposal Conference held on September 4, 2013 in Washington DC are included as an attachment to this solicitation.
Added: Oct 18, 2013 7:12 am
Summary: The first cutoff date for quad charts and white papers is extended to November 15, 2013. A correction is made to the seventh cutoff date.
Added: Jun 12, 2015 10:38 am
OraQuick Ebola Rapid Antigen Test
Added: Jul 27, 2015 6:43 pm
The closing date of this Broad Agency Annoucement is hereby extended from July 31, 2015 through October 31, 2015.
Please consult the list of document viewers if you cannot open a file.

Solicitation 1

Posted Date:
July 31, 2013
Description: Broad Agency Announcement

Pre-Proposal Conference Slides

Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Pre-Proposal Conference Slides
Posted Date:
September 6, 2013
Description: Pre-Proposal Conference Slides

Amendment 1

Posted Date:
October 18, 2013
Amendment_1.pdf (65.23 Kb)
Description: Amendment 1

Amendment 2

Posted Date:
June 6, 2014
Amendment_2.pdf (170.26 Kb)
Description: Summary of Changes - Amendment 2.
Description: Conformed Copy of CBRN-BAA-13-100-SOL-00013 through Amendment 2
Office of the Assistant Secretary for Preparedness & Response (ASPR)
Department of Health and Human Services
330 Independence Ave. SW
Washington, District of Columbia 20201
United States
Joseph A. Tam Lung,
Contract Specialist
Phone: 202-205-2860
Matthew A. McCord,
Contracting Officer
Phone: 202-260-0689